AstraZeneca plc — #31 MNC Inclusion Index | PrideShow Ranking 2026-q2

British-Swedish multinational pharmaceutical company (LSE: AZN; NASDAQ: AZN). Focus areas: oncology, cardiovascular + renal + metabolic, respiratory, vaccines + immune therapies. $45bn revenue 2023. 89,000+ employees. AstraZeneca Thailand manages COVID-19 vaccine supply + innovative-medicines portfolio.

Embed this ranking

Add the badge to your site or IR page:

<img src="https://prideshow.org/api/badge/ranking/2026-q2/astrazeneca?style=seal" alt="Ranked #31 in PrideShow Ranking 2026-q2" width="150" />

View full MNC directory profile → →